Altrius Pharmaceuticals LLC is categorized under Commercial Biotechnical Research in Cambridge, MA and active since 2012.
Altrius Pharmaceuticals LLC was established in 2012, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Susie Harborth at the company’s single location by writing to 1 Broadway Floor 14, Cambridge, Massachusetts MA 02142 or by phoning (617) 276-5578. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Altrius Pharmaceuticals LLC |
Contact Person: | Susie Harborth |
Address: | 1 Broadway Floor 14, Cambridge, Massachusetts 02142 |
Phone Number: | (617) 276-5578 |
Annual Revenue (USD): | $50.000 to $99.999 |
Founded: | 2012 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Commercial Biotechnical Research |
SIC Code: | 8731 |
NAICS Code: | 541711 |
Share This Business: |
Altrius Pharmaceuticals LLC was started in 2012 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Susie Harborth for inquiries that concern Altrius Pharmaceuticals LLC by calling the company number (617) 276-5578, as your correspondence is most welcome. Additionally, the physical location of the single location of Altrius Pharmaceuticals LLC can be found at the coordinates 42.362362,-71.083313 as well as the street address 1 Broadway Floor 14 in Cambridge, Massachusetts 02142.
For its online presence, you may visit Altrius Pharmaceuticals LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.